健之佳: 第六届董事会第十二次会议决议公告

Group 1 - The board of directors of Jianzhijia Pharmaceutical Chain Group Co., Ltd. held its 12th meeting of the 6th session on August 28, 2025, with all 7 directors present and voting [1] - The board approved a proposal to cancel the supervisory board, establish employee directors, and amend the company's articles of association, which will be submitted for shareholder approval [2][3] - The company aims to improve its governance structure and operational norms by adding and revising several internal regulations, including a new "Management System for Departing Directors and Senior Management" and revisions to the "Audit Committee Work Guidelines" among 12 other documents [2]